Evidence map›Paper›PMID 9371556›Full record

ArticleJournal of virology1997

Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses.

J Rucker, A L Edinger, M Sharron, M Samson, B Lee, J F Berson, Y Yi, B Margulies, R G Collman, B J Doranz and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it, 310 citations in OpenAlex.

  1. The Hitchhiker Guide to CD4Frontiers in immunology · 2021
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

J RuckerDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104, USA.
A L Edinger
M Sharron
M Samson
B Lee
J F Berson
Y Yi
B Margulies
R G Collman
B J Doranz
M Parmentier
R W Doms
University of Pennsylvania · US

Funding

HIV entry and its inhibitionR01AI040880 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DOMS, ROBERT W. · 1997 to 2010
$4.2M
MOLECULAR PATHOGENESIS OF AIDS RELATED CNS DISEASET32NS007392 · NINDS · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE ELLEN · 1995 to 2005
$895k
NEUTRALIZING ANTIBODIES SPECIFIC FOR OLIGOMERIC HIV1 ENVR01AI035383 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DOMS, ROBERT W. · 1994 to 2002
$857k
HUMORAL IMMUNITY TO OLIGOMERIC SIV ENVELOPE GLYCOPROTEINR01AI038225 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI HOXIE, JAMES A · 1995 to 1998
–
NIAID NIH HHS AI-35383NIAID NIH HHS AI-38225NIAID NIH HHS AI-40880NIAID NIH HHS R01 AI040880NINDS NIH HHS T32 NS007392
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) requires both CD4 and a coreceptor to infect cells. Macrophage-tropic (M-tropic) HIV-1 strains utilize the chemokine receptor CCR5 in conjunction with CD4 to infect cells, while T-cell-tropic (T-tropic) strains generally utilize CXCR4 as a coreceptor. Some viruses can use both CCR5 and CXCR4 for virus entry (i.e., are dual-tropic), while other chemokine receptors can be used by a subset of virus strains. Due to the genetic diversity of HIV-1, HIV-2, and simian immunodeficiency virus (SIV) and the potential for chemokine receptors other than CCR5 or CXCR4 to influence viral pathogenesis, we tested a panel of 28 HIV-1, HIV-2, and SIV envelope (Env) proteins for the ability to utilize chemokine receptors, orphan receptors, and herpesvirus-encoded chemokine receptor homologs by membrane fusion and virus infection assays. While all Env proteins used either CCR5 or CXCR4 or both, several also used CCR3. Use of CCR3 was strongly dependent on its surface expression levels, with a larger number of viral Env proteins being able to utilize this coreceptor at the higher levels of surface expression. ChemR1, an orphan receptor recently shown to bind the CC chemokine I309 (and therefore renamed CCR8), was expressed in monocyte and lymphocyte cell populations and functioned as a coreceptor for diverse HIV-1, HIV-2, and SIV Env proteins. Use of ChemR1/CCR8 by SIV strains was dependent in part on V3 loop sequences. The orphan receptor V28 supported Env-mediated cell-cell fusion by four T- or dual-tropic HIV-1 and HIV-2 strains. Three additional orphan receptors failed to function for any of the 28 Env proteins tested. Likewise, five of six seven-transmembrane-domain receptors encoded by herpesviruses did not support Env-mediated membrane fusion. However, the chemokine receptor US28, encoded by cytomegalovirus, did support inefficient infection by two HIV-1 strains. These findings indicate that additional chemokine receptors can function as HIV and SIV coreceptors and that surface expression levels can strongly influence coreceptor use.

Indexed as

Chemokines, CCAnimalsChemokine CCL1CX3C Chemokine Receptor 1HeLa CellsHerpesviridaeHIV-1HIV-2HumansMembrane FusionReceptors, CCR3Receptors, CCR8Receptors, ChemokineReceptors, CytokineReceptors, HIVReceptors, VirusCCL1 protein, humanCCR3 protein, humanCCR8 protein, humanChemokine CCL1Chemokines, CCCX3C Chemokine Receptor 1Receptors, CCR3Receptors, CCR8Receptors, ChemokineReceptors, CytokineReceptors, HIVReceptors, Virus

Identifiers

PMID9371556
PMCPMC230200
OpenAlexW2116296362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.